Cancer staging is a key part of mesothelioma diagnosis and treatment. Knowing how far the cancer has spread helps doctors decide which treatments to use. For example, doctors use cancer stage as a guideline when deciding whether a patient is likely to benefit from surgery.
Early-stage patients may benefit from surgery by living longer and experiencing fewer symptoms. Late-stage patients benefit more from treatment focused on symptom management. The goal of treatment in all stages is to improve quality of life and help people live longer.
Because mesothelioma symptoms don’t develop until later stages, most patients are not diagnosed until stage 3 or 4. The cancer’s cell type and the patient’s overall health also affect treatment options.
The most common treatment for mesothelioma is chemotherapy. Some patients get diagnosed early enough to qualify for surgery. Surgery is often combined with chemotherapy and radiation therapy to kill more cancer cells. Clinical trials are testing new therapies such as immunotherapy.
Stages of Mesothelioma
The stages of pleural mesothelioma are based upon the size of tumors and how far they have spread. The location and size of tumors has a direct impact on the symptoms a person may feel.
Tumor size and location also determines whether a person can undergo surgery. Unfortunately, surgery is no longer an option when tumors become too big or spread too far.
Initially, tumor growth is within a single area. The life expectancy of stage 1 mesothelioma is significantly better than later stages. It is difficult to catch the cancer this early because people with this stage do not usually experience symptoms.
Major surgery to remove the cancer is the first line of treatment. Doctors usually recommend an aggressive multimodal approach including surgery, chemotherapy, radiation therapy or immunotherapy.
Median life expectancy at stage 1 is 22.2 months with surgery.Learn more about stage 1 mesothelioma
Stage 2 symptoms are vague and mild, and patients and doctors often mistake them for signs of other illnesses such as the flu.
The available treatment options are generally the same as for stage 1 mesothelioma. Median life expectancy at stage 2 is 20 months with surgery.Learn more about stage 2 mesothelioma
Once the cancer progresses to stage 3, it may have spread to several tissues, organs and lymph nodes in the same region of the body where it formed.
Pleural mesothelioma patients may have difficulty breathing and chest pain even when resting. Discomfort may be felt in other parts of the body as well.
Some stage 3 cancer patients are ineligible for surgery and other aggressive treatments. At that point, doctors offer palliative options.
Median life expectancy at stage 3 is 17.9 months with surgery.Learn more about stage 3 mesothelioma
By stage 4, cancer has spread to other parts of the body. Cancer could be present in the liver, brain, bones or elsewhere. Patients may experience extreme difficulty breathing and swallowing, digestive problems and severe pain.
For stage 4 patients, doctors typically fall back on palliative treatments designed to ease pain and control other symptoms. Most stage 4 patients do not qualify for surgery.
Median life expectancy at stage 4 is 14.9 months or less with or without surgery.Learn more about stage 4 mesothelioma
Stages for Different Types of Mesothelioma
Pleural mesothelioma is the only type of this cancer that has an official staging system.
Researchers are working on formalizing a staging system for peritoneal mesothelioma, which currently only has three defined stages.
Patients generally don’t experience any symptoms in the early stages of peritoneal mesothelioma. As the cancer progresses, patients may lose weight but feel bloated.
In the later stages of peritoneal mesothelioma, patients typically experience abdominal pain and digestive problems.
The fourth stage of peritoneal mesothelioma is generally accepted as the stage where the cancer has spread to other parts of the body. The reason doctors haven’t officially defined a fourth stage is because the current staging system is based upon patients who qualified for surgery.
Only early-stage patients qualify for surgery, which means researchers did not study enough late-stage patients to clearly define a fourth stage.
There are no staging systems for pericardial mesothelioma or testicular mesothelioma.
Find a Mesothelioma Specialist Near You
We'll help you or a loved one find the most qualified mesothelioma specialists and treatment facilities in your area.Get Help Now
Effect of Mesothelioma Stages on Life Expectancy & Prognosis
People diagnosed in early stages of mesothelioma have a better prognosis and longer life expectancy. Some people with late-stage mesothelioma have lived for years with the disease, but it is less common.
Research shows varying survival rates for each stage of mesothelioma. These survival statistics tell you what portion of people with the same type and stage of cancer are alive years after diagnosis.
These figures can’t tell you how long you will live. Every patient is different. Even though late-stage patients tend to not live as long, some far outlive the average prognosis.
Survival rates are different for peritoneal mesothelioma and pleural mesothelioma. People with peritoneal mesothelioma tend to live longer.
Two-year and five-year survival rates are available for pleural mesothelioma. The following figures are based upon patients who were diagnosed between 2000 and 2013.
|Stage||2-Year Survival Rate||5-Year Survival Rate|
|Stage 4||17%||Less than 1%|
|Stage 4||Not Available*|
* Survival rate data is not available because a fourth stage hasn’t been defined yet.
Mesothelioma Stages Symptoms
People wonder if they can determine their stage based on their symptoms. Unfortunately, the symptoms of mesothelioma are not strongly correlated with the stages.
|Stages||Pleural Mesothelioma||Peritoneal Mesothelioma|
|Stage 1||No symptoms are associated with stage 1||No symptoms are associated with stage 1|
|Stage 2||While rare, patients may experience symptoms that resemble the common cold such as difficulty breathing during exercise or a mild cough||Peritoneal patients may lose weight or feel bloated|
|Stage 3||Difficulty breathing, dry cough, wheezing, fluid around the lungs and chest pain||Digestive problems (constipation or diarrhea) and abdominal pain|
|Stage 4||Extreme difficulty breathing, trouble swallowing, severe chest pain, loss of appetite, weight loss, muscle weakness, night sweats, fever and fatigue||Constant digestive problems, weight loss, swelling of the abdomen (abdominal distension), bowel obstruction, loss of appetite, fever, night sweats, fatigue and difficulty breathing or swallowing|
One of the reasons mesothelioma tends to be diagnosed in a late stage is the fact that early stages of mesothelioma cause no symptoms. The cancer is small in early stages and does not affect the body the way larger, late-stage tumors do.Learn more about mesothelioma symptoms
Mesothelioma Staging Systems
There are three systems for mesothelioma staging: TNM, Brigham and Butchart.
TNM is the most widely used and accepted staging system for pleural mesothelioma.
A TNM staging system is in the works for peritoneal mesothelioma, but it has not been officially adopted yet. There are currently no formal staging systems for the other types of mesothelioma.
If you are diagnosed with mesothelioma, you should seek a second opinion to make sure your cancer has been staged correctly.
Many oncologists do not have experience with asbestos-related cancers. Always find a doctor who does.Learn more about mesothelioma staging systems
Improving Staging Methods
Doctors are working to improve the ways they stage mesothelioma. The goal is to accurately stage the cancer with minimally invasive procedures.
Currently, the most accurate way to stage mesothelioma is with surgery.
Doctors do their best to estimate the stage without surgery. They use imaging scans and biopsies, which are less invasive than surgery.
These techniques come close to estimating a patient’s true stage, but often they over- or under-stage cancer. This inaccurate staging results in patients not receiving the best treatments for their true stage.
An improved approach to estimating stage is under development. Doctors are using new methods to analyze imaging scans.
These new methods measure the volume and thickness of tumors in the images. The measurements give doctors a better understanding of how far the cancer has grown and spread, which leads to more accurate staging.
Improvements to staging methods will help ensure patients receive the most effective treatments. This could result in longer survival rates among people diagnosed with mesothelioma regardless of their stage.
Share this article
Last Modified September 28, 2018
19 Cited Article Sources
Chahinian, A., & Robinson, B. Mesothelioma. London: Martin Dunitz, 2002.
Butchart, E.G., et al. (1976). Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Thorax.
Retrieved from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC470356/pdf/thorax00145-0021.pdf
Vanderbilt University Medical Center. (n.d.). Department of Thoracic Surgery - Mesothelioma.
Retrieved from: http://www.mc.vanderbilt.edu/root/vumc.php?site=thoracic&doc=3594
American College of Chest Physicians. (1995). A proposed new international TNM staging system for malignant pleural mesothelioma.
Retrieved from: http://mdmeso.com/wp-content/uploads/2015/05/A-Proposed-New-INternational-TNM-Staging-System-for-Malignant-Pleural-Mesothelioma.pdf
Baldi, A. (Ed.). Mesothelioma from bedside to clinic. New York, NY: Nova Science Publishers, Inc., 2008.
Dodson, R.F., & Hammar, S. P. (Eds.). Asbestos: Risk assessment, epidemiology, and health effects. Boca Raton, FL: Taylor & Francis Group, 2006.
National Cancer Institute. (2015, March 9). Cancer staging.
Retrieved from: http://www.cancer.gov/cancertopics/factsheet/detection/staging
O’Bryne, K., & Rusch, V. (Eds.). Malignant pleural mesothelioma. New York, NY: Oxford University Press, 2006.
Pass, H., Vogelzang, N. & Carbone, M. Malignant Mesothelioma: Advances in pathogenesis, diagnosis, and transitional therapies. New York: Springer, 2005.
Patz, E. F., Jr., Rusch, V. W., & Heelan, R. (1996). The proposed new international TNM staging system for malignant pleural mesothelioma: Application to imaging. American Journal of Roentgenology, 166, 323-327.
Kadota, K. et al. (2012). A nuclear grading system is a strong predictor of survival in epithelioid diffuse malignant pleural mesothelioma. Mod Pathol, 25(2), 260–271. doi: 10.1038/modpathol.2011.146
American Cancer Society. (2016, February 17). Treatment of Mesothelioma Based on the Extent of the Cancer.
Retrieved from: https://www.cancer.org/cancer/malignant-mesothelioma/treating/by-extent.html
NYU Langone Medical Center. (n.d.). Is your patient a candidate?
Retrieved from: http://hipec.med.nyu.edu/physicians/your-patient-candidate
American Cancer Society. (2017, December 20). Malignant mesothelioma stages.
Retrieved from: https://www.cancer.org/cancer/malignant-mesothelioma/detection-diagnosis-staging/staging.html
Tan, W.W. (2016, January 4). Malignant pleural mesothelioma staging.
Retrieved from: https://emedicine.medscape.com/article/1999306-overview
Nowak, A.K. et al. (2016). The IASLC mesothelioma staging project: proposals for revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma. Journal of Thoracic Oncology, 11(12), 2089-2099. doi: 10.1016/j.jtho.2016.08.147
Bonomi, M. et al. (2017). Clinical staging of malignant pleural mesothelioma: Current perspectives. Lung Cancer: Targets and Therapy, 8, 127-139. doi: 10.2147/LCTT.S102113
Yan, T.D. et al. (2011). A Novel Tumor-Node-Metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database. Cancer, 117(9), 1855-1863.
- Gill, R.R. et al. (2017). Quantitative clinical staging for patients with malignant pleural mesothelioma. Retrieved from: https://academic.oup.com/jnci/article/110/3/djx175/4222833